Abbott Agrees to Pay Over $384M to Settle Allegations Related to Contaminated Infant Formula
Abbott Laboratories (Abbott), an Illinois-based healthcare company that manufactures and sells infant formula and nutritional therapy products, has agreed to pay $384,999,040 to resolve allegations that it caused false claims to be submitted between Jan. 1, 2018, and Dec. 31, 2022, to federal and state programs arising from its failure to manufacture certain powder infant formula and nutritional therapy products...
What happened
Abbott Laboratories (Abbott), an Illinois-based healthcare company that manufactures and sells infant formula and nutritional therapy products, has agreed to pay $384,999,040 to resolve allegations that it caused false claims to be submitted between Jan. 1, 2018, and Dec. 31, 2022, to federal and state programs arising from its failure to manufacture certain powder infant formula and nutritional therapy products...
Why it matters
The development may change operating conditions or market expectations around Regulation. Further confirmation and measurable outcomes matter.
Affected entities
View evidence
1 reports · 1 original report · 1 independent
- U.S. Department of JusticePrimary source · Supports · EN · 100%Abbott Agrees to Pay Over $384M to Settle Allegations Related to Contaminated Infant Formula ↗
Claims
- Abbott Agrees to Pay Over $384M to Settle Allegations Related to Contaminated Infant Formula Observed
Conflicts
No material conflict detected in the available evidence.
Timeline
- First reported
Market move following event
Market reaction is not yet available for this asset and time window.